Clinical Trials Browser

Phase 2 × Breast Diseases × Vinorelbine × Clear all

NCT04605575 2022-04-26

Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer

Phase 2 Unknown

Breast Diseases, Breast Neoplasms